Purple Biotech (PPBT) Prepaid Assets (2017 - 2026)
Purple Biotech (PPBT) reported Prepaid Assets of $353000.0 for Q1 2026, down 17.52% year-over-year from $428000.0 in Q1 2025, and up 20.89% quarter-over-quarter from $292000.0 in Q4 2025.
Purple Biotech (PPBT) Prepaid Assets (2017 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 10 years of Prepaid Assets data on file, last reported at $353000.0 in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $353000.0, down 17.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $353000.0 (down 17.52% YoY), and the FY2025 annual result was $292000.0, up 6.18% from the prior year.
- Prepaid Assets rose to $353000.0 in Q1 2026 per PPBT's latest filing, from $292000.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $2.4 million in Q1 2022 and troughed at $275000.0 in Q4 2024.
- A 5-year average of $773823.5 and a median of $548000.0 in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets soared 57.96% in 2022, then tumbled 67.1% in 2023.
- A 5-year view of Prepaid Assets shows it stood at $1.1 million in 2022, then plunged by 67.1% to $376000.0 in 2023, then retreated by 26.86% to $275000.0 in 2024, then rose by 6.18% to $292000.0 in 2025, then rose by 20.89% to $353000.0 in 2026.
- Business Quant data shows PPBT's Prepaid Assets at $353000.0 in Q1 2026, $292000.0 in Q4 2025, and $320000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Purple Biotech | 242.86 Mn | 236.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 353,000.00 |
| Dec 31, 2025 | 292,000.00 |
| Sep 30, 2025 | 320,000.00 |
| Jun 30, 2025 | 394,000.00 |
| Mar 31, 2025 | 428,000.00 |
| Dec 31, 2024 | 275,000.00 |
| Sep 30, 2024 | 638,000.00 |
| Jun 30, 2024 | 473,000.00 |
| Mar 31, 2024 | 548,000.00 |
| Dec 31, 2023 | 376,000.00 |
| Sep 30, 2023 | 634,000.00 |
| Jun 30, 2023 | 984,000.00 |
| Mar 31, 2023 | 1.29 Mn |
| Dec 31, 2022 | 1.14 Mn |
| Sep 30, 2022 | 1.22 Mn |
| Jun 30, 2022 | 1.43 Mn |
| Mar 31, 2022 | 2.35 Mn |
| Dec 31, 2021 | 1.27 Mn |
| Sep 30, 2021 | 1.13 Mn |
| Jun 30, 2021 | 1.12 Mn |